Pharma
Pharma·
Lilly’s Foundayo Wins EU Panel Nod — Brussels Bureaucracy Gets a Rare Win
Pharma·
China Tightens Biotech Export Rules — But Leaves the Licensing Door Ajar
Pharma·
City Therapeutics Upsizes $200 Million IPO — RNAi Pipeline Wins Wall Street Bet
Pharma·
FDA Uncovers Black Mold in Chinese Plants Supplying Compounded GLP-1 Drugs
Pharma·
Ebola Spreads to Eighth Congo Province as Young Children Face Heavy Toll

Pharma·
RevMed’s Pancreatic Cancer Drug Wins EU Panel Backing — A Win for Real Medicine Over Bureaucratic Drag
Pharma·
Biocon's Kiran Mazumdar-Shaw Sees AI Shortening Clinical Trials as the Real Prize

Pharma·
AI Drug Discovery Is a Capitalist Win — Bureaucrats Need Not Apply

Pharma·
GLP-1 Drugs Cut Schizophrenia Relapses in New US Study
Pharma·
FDA’s Rare-Disease Overhaul: Regulators Finally Notice They’re the Bottleneck
Pharma·
Gene-Edited Mosquitoes: A Market Test Worth Running
Pharma·
Olympus Shares Tank as FDA Warning Letter Exposes Six-Plant Weakness

Pharma·
Zealand Pharma Lands $1.2 Billion AI-Powered Obesity Bet With Generate

Pharma·
BioNTech's Experimental Cancer Drug Flops in Early Head-and-Neck Trial

Pharma·
J&J Beats on New Drugs, Lifts Guidance — Medical Devices the Drag

Pharma·
Bristol Myers' Late-Stage Wins: Two New Drugs Clear the Bar
Pharma·
Russia Plague Death Spotlights Vaccine Gaps and WHO Ineptitude
Pharma·
Bambusa Therapeutics Files for IPO to Finance Eczema Drug Trials

Pharma·
Eli Lilly-Backed TRex Bio Grabs $116.7 Million in IPO — Priced at the Bottom, Still a Win
Pharma·
J&J Skips Obesity, Doubles Down on Cancer and AI Drug Discovery

Pharma·
Tick-Borne Lyme Disease Surges, Drugmakers Race for Vaccines and Blockers
Pharma·
Weight-Loss Drugs May Ease Joint Pain, But They Are No Free Lunch
Pharma·
India's Supreme Court Targets Pharma Sales Tactics — Another Regulatory Hammer Heads for the Industry
Pharma·
Shanghai Allist Plunges 20% as ArriVent Trial Collapse Kills Global Hopes
Pharma·
Russia's Plague Lab Death: Bureaucratic Fog Over a Dead Worker
Pharma·
Merck Loses Keytruda Franchise Protection as European Courts Block Injectable Version
Pharma·
WHO Blocks Obesity Drugs for Kids Under 10 — Bureaucrats Over Parents Again
Pharma·
Eli Lilly-Backed TRex Bio Files for $133.3 Million IPO

Pharma·
Nobel for Optogenetics Hands Investors a New Biotech Frontier
Pharma·